Andy Renshaw was inducted as president

For Immediate Release

 

Date:               November 4, 2012
Phone:             (302) 543-6583
Fax:                 (302) 543-6597

 

2012-2013 American Society of Cytopathology

Executive Board and Officers

 

November 4, 2012, Wilmington, Delaware–The American Society of Cytopathology will be announcing its new officers and Executive Board members for 2012-2013 as follows, during the ASC Annual Business Meeting on November 4th in Las Vegas, during the ASC 60th Annual Scientific Meeting.

 

 

American Society of Cytopathology Officers
 

President

Andrew Renshaw, MD
Baptist Hospital of Miami
Department of Pathology
Miami Florida

Vice-President

Michael R. Henry, MD
Mayo Clinic and Foundation
Rochester, Minnesota 

President-Elect

Ritu Nayar, MD
Northwestern Memorial Hospital
Chicago, Illinois

Secretary-Treasurer

Daniel F.I. Kurtycz, MD
Wisconsin State Laboratory of Hygiene
Madison, Wisconsin


ASC Executive Board Members

Joel S. Bentz, MD (2013)
Laboratory Medicine Consultants, Ltd.
Las Vegas, Nevada 

Jill L. Caudill, MEd, SCT(ASCP)CM (2013)
Mayo School of Health-Related Sciences
Rochester, Minnesota 

Eva M. Wojcik, MD, MIAC (2013)
Loyola University Medical Center
Maywood, Illinois 

Rosemary Tambouret, MD (2014)
Massachusetts General Hospital
Boston, Massachusetts 

Amy J. Wendel Spiczka, MS, SCT, MB, HTL(ASCP)CM (2014)
Mayo Clinic and Foundation
Scottsdale, Arizona

Philip T. Valente, MD (2014)
University of Texas Health Science Center
San Antonio, Texas 

David F. Chhieng, MD (2015)
Yale University
New Haven, Connecticut

Jeffrey F. Krane, MD (2015)
Brigham & Women's Hospital
Boston, Massachusetts

Lynnette C. Savaloja, SCT(ASCP) (2015)
Regions Hospital
Saint Paul, Minnesota

Tarik Elsheik, MD (2016)
Cleveland Clinic Foundation
Cleveland, Ohio

Kalyani Naik, MS, SCT(ASCP) (2016)
University of Michigan Hospital
Ann Arbor, Michigan

Patricia Wasserman, MD (2016)
Columbia University Medical Center
New York, New York

Lydia Howell, MD, Past President
University of California
Davis Medical Center
Sacramento, California

Ann T. Moriarty, MD, ex officio
ASC Foundation Co-Chair
Ameripath
Indianapolis, Indiana

William N. Crabtree, PhD, SCT(ASCP),ex officio
ASC Foundation Co-Chair

Indiana University School of Medicine
Indianapolis, Indiana
  

The Officers and new Executive Board Members will be installed on November 4, 2012 during the ASC’s 60th Annual Scientific Meeting.  The ASC Executive Board is the general management of the American Society of Cytopathology.  The Board regularly performs the ordinary duties of a board of directors to appoint any Committee it may deem necessary and to delegate whatever powers necessary to the Committees.  Executive Board Members are elected to serve a four-year term on the Board. 

The ASC, founded in 1951, is a distinguished national professional society of physicians, cytotechnologists and scientists who are dedicated to the detection and early diagnosis of nearly all forms of cancer.  The ASC is the largest medical society solely devoted to recognizing cellular abnormalities in order to benefit patients. The majority of tests that the ASC Members interpret are Pap tests.  The ASC’s diverse membership of more than 3000 individuals includes representatives from other countries who share a vision of education, research and continuous improvement in the standards and quality of patient care.  The ASC is a unique society that provides a forum where physicians and cytotechnologists can interact and network with each other on both a personal and professional level.

 

Additional information on the American Society of Cytopathology may be obtained from:

American Society of Cytopathology, 100 West 10th Street, Suite 605, Wilmington, DE 19801; telephone: (302) 543-6583, fax: (302) 543-6597, e-mail: asc@nullcytopathology.org, web site:  www.cytopathology.org.